# Radient Pharmaceuticals Corporation (RPC) - Q1 2026 earnings

Reported May 7, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $75.0M | $77.0M |
| EPS | $0.22 | $0.21 |

Earnings filing reader: [8-K 0001193125-26-213371](https://www.opencapital.sh/filings/0001193125-26-213371)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-213371.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1841968/000119312526213371/0001193125-26-213371-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1841968/000119312526213908/0001193125-26-213908-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/rpc/earnings/q1-2026